Q2 2025 Earnings Call Transcript February 12, 2025 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.26, ...

Repositrak Inc. (NASDAQ: TRAK) reported its Q2 FY2025 earnings, showing a slight miss in both earnings per share (EPS) and revenue compared to forecasts. The company recorded an EPS of $0.08, below ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...